As shown in Fig 7, the killing ability of CIK cells from one donor against ovarian cancer cells was weaker than K562 cells with the killing activity of less than 15%, while CD8+ CIK cell killing activity against ovarian cancer cells were more than 50%, with the strongest effect on OVCAR3 cells (Fig 7). Here, CD8A is linked to ovarian carcinoma.